Skip to main content

Adiposity and grip strength: a Mendelian randomisation study in UK Biobank



Muscle weakness, which increases in prevalence with age, is a major public health concern. Grip strength is commonly used to identify weakness and an improved understanding of its determinants is required. We aimed to investigate if total and central adiposity are causally associated with grip strength.


Up to 470,786 UK Biobank participants, aged 38–73 years, with baseline data on four adiposity indicators (body mass index (BMI), body fat percentage (BF%), waist circumference (WC) and waist-hip-ratio (WHR)) and maximum grip strength were included. We examined sex-specific associations between each adiposity indicator and grip strength. We explored whether associations varied by age, by examining age-stratified associations (< 50 years, 50–59 years, 60–64 years,65 years +). Using Mendelian randomisation (MR), we estimated the strength of the adiposity–grip strength associations using genetic instruments for each adiposity trait as our exposure.


In males, observed and MR associations were generally consistent: higher BMI and WC were associated with stronger grip; higher BF% and WHR were associated with weaker grip: 1-SD higher BMI was associated with 0.49 kg (95% CI: 0.45 kg, 0.53 kg) stronger grip; 1-SD higher WHR was associated with 0.45 kg (95% CI:0.41 kg, 0.48 kg) weaker grip (covariate adjusted observational analyses). Associations of BMI and WC with grip strength were weaker at older ages: in males aged < 50 years and 65 years + , 1-SD higher BMI was associated with 0.93 kg (95% CI: 0.84 kg, 1.01 kg) and 0.13 kg (95% CI: 0.05 kg, 0.21 kg) stronger grip, respectively. In females, higher BF% was associated with weaker grip and higher WC was associated with stronger grip; other associations were inconsistent.


Using different methods to triangulate evidence, our findings suggest causal links between adiposity and grip strength. Specifically, higher BF% (in both sexes) and WHR (males only) were associated with weaker grip strength.

Peer Review reports


Muscle weakness is a major public health concern. Its prevalence increases markedly with age, and it is a key component of age-related conditions such as sarcopenia and frailty [1], which are associated with mobility disability and loss of independence. Hence, the burden of muscle weakness is substantial and shared between individuals, their families and society [2,3,4]. Measures of muscle weakness are strong predictors of functional decline[5] and against the backdrop of an ageing population [6], the disease and disability burden associated with muscle weakness will continue to rise unless effective public health strategies aimed at reducing its occurrence are implemented. Low absolute grip strength, commonly used to identify muscle weakness, predicts fractures, cardiovascular disease and all-cause mortality [7,8,9,10]. Grip strength increases to a peak in early adulthood and is maintained through to mid-life and subsequently declines; but within any one age group, considerable between-individual heterogeneity in strength is evident [11]. While both genetic and environmental factors over the life course are associated with grip strength across adulthood [12, 13], an improved understanding of the causal determinants of strength is still required to help develop effective strategies to prevent or delay the onset of muscle weakness.

Like muscle weakness, adiposity (usually assessed in population-based studies by body mass index (BMI), body fat percentage (BF%), waist circumference (WC) and/or waist-hip-ratio (WHR)) is also associated with a myriad of adverse outcomes including functional decline and premature mortality [5, 14,15,16]. Obesity is currently highly prevalent in all age groups [17], and BMI and BF% tend to increase with age [18, 19]. Thus, when current generations of younger adults reach older ages, they are more likely to have been overweight or obese for longer proportions of their lives [18] and so have a higher body fat mass than contemporaneous older adults. This has potentially concerning implications for a multitude of age-related outcomes including muscle weakness. Therefore, establishing the influence of lifetime adiposity on strength has become increasingly important.

Most studies exploring associations between adiposity and absolute grip strength have been limited to BMI and findings have been inconsistent with studies showing associations of higher BMI with both weaker [20] and stronger [21] absolute grip, associations in men only [22] or no association [23]. Discrepant findings could be due to differences in age at the time of grip strength assessment or variations in birth cohort and/or country of study. Reliance on BMI as the main marker of adiposity could be another contributing factor. Although BMI provides a quick and easy assessment of total adiposity, it does not distinguish between lean and fat mass. This lack of differentiation is a key limitation when examining relationships with characteristics of muscle, such as strength. In such situations, a more appropriate marker of total adiposity could be BF%, but population-based studies examining relationships between BF% and strength are scant [24]. In addition, while markers of total adiposity are valuable, they do not reflect body fat distribution, and central adiposity has been shown to be a stronger predictor of many health outcomes than total adiposity [15, 16]. For example, central adiposity is characterized by a state of chronic low-grade inflammation, which in turn is associated with lower muscle strength [25, 26]. Yet, few studies have related central adiposity (usually assessed by WC and WHR) to grip strength [21, 22, 24]. Moreover, regardless of the measure of adiposity examined, all observational studies relating adiposity to grip strength suffer from unmeasured and/or residual confounding. For example, capturing information on resistance training which influences strength [27] and may influence adiposity [28] is difficult in large scale studies. Thus, in observational studies, it is not always straightforward to quantify the true effects of adiposity on muscle strength.

Given the importance of understanding whether adiposity causally influences muscle strength and the methodological limitations of existing studies, we aimed to establish the role of total (BMI, BF%) and central (WC, WHR) adiposity on grip strength using UK Biobank data. In an observational analysis, we examined associations between the four indicators of adiposity and grip strength cross-sectionally. To help triangulate evidence on the effect of adiposity on grip strength, we also used an alternative analytic approach—Mendelian randomisation (MR)—to estimate the strength of the same associations using genetic instruments for each of the four different adiposity indicators. Due to evidence of sex-differences in BMI-grip strength associations in previous studies [22], and marked sex-differences in grip strength [11], we chose a-priori to run all analyses stratified by sex.


UK Biobank [29, 30] is a prospective study of over 500,000 UK adults aged 38–73 years at recruitment (2006–2010). Participants, recruited across the UK from National Health Service central registers, provided informed consent; ethical approval was given by the North West Multicentre Research Ethics Committee. Our study included only white European participants because the genome-wide association studies (GWAS) used to identify genetic instruments (described below) were primarily based on European samples. The analysis sample of white Europeans with a valid measure of grip strength varied from 470,786 for observational analysis (214,406 males and 256,380 females) to 407,487 for MR analysis (187,245 males and 220,242 females); details are in Fig. 1.

Fig. 1
figure 1

Flow diagram of UK Biobank participants and study design. M, males; F, females; SNP, single-nucleotide polymorphism; G-XGWAS, genetic association of adiposity (BMI, BF%, WC and WHR) instruments (SNPs) with BMI, BF%, WC and WHR respectively from relevant GWAS (see methods for details); G-GSUKB, genetic association of adiposity instruments (SNPs) with grip strength in UK Biobank

Adiposity measures were ascertained following standardised protocols [29]. Weight (without shoes and heavy outer clothing) and BF% were measured using a Tanita BC-418 MA body composition analyser. Height was measured with a Seca 202 height measure; waist and hip circumferences were measured using a tape measure [29]. BMI (kg/m2) and WHR were calculated.

Grip strength was assessed using a Jamar J00105 hydraulic hand dynamometer. Participants sat upright in a chair with their forearms on armrests. They were asked to squeeze the dynamometer’s handle as hard as they could with their right hand for about 3 seconds. The grip strength measurement was then repeated using the same protocol for the left hand [31]. We examine the maximum recorded value (greater than 0) from either hand.

Potential confounders identified a priori, for examined observational associations, are described in detail elsewhere [32]. They included age; deprivation (defined by the Townsend score

[33]); smoking status (never, ex-, current); physical activity (number of days/week participants undertook > 10 min of moderate and vigorous activity, recorded as two separate categorical variables) and average alcohol intake over the last year (rarely/never, once/month to twice/week and ≥ twice/week).

Adiposity genetic instruments

We used single nucleotide polymorphisms (SNPs) identified from the largest European descendent GWAS to date [34,35,36,37], as our genetic instruments for BMI, BF%, WC and WHR (620, 6, 46 and 319 near-independent SNPs, respectively). The SNPs in our genetic instruments were regressed onto the adiposity measure under consideration and the R-squared and F-statistic calculated. Our instruments explained 0.24% (BF%) to 5.81% (BMI) of the variability in adiposity traits in men and 0.17% (BF%) to 5.22% (BMI) in women. The F-statistic varied from 14.90 (WHR) to 73.83 (BF%) in men and from 19.45 (BMI) to 61.52 (BF%) in women (Additional File 1: Table S1). We used genotype dosage information to estimate allele count under an additive genetic model. Instrument details are provided in Additional File 1: Table S2; information on the genetic instrument selection process is provided briefly in Additional File 2: Fig. S1 and in detail elsewhere [38, 39].

Statistical methods

Due to evidence of sex-differences in BMI–grip strength associations in previous studies [22], and marked sex-differences in grip strength [11], we chose a-priori to run all analyses stratified by sex. Figure 1 illustrates our study design, which includes examination of both observational and genetic associations.

Correlations between phenotypic and genetic adiposity measures and traits

We calculated pair-wise phenotypic correlations between adiposity measures using Pearson’s correlation coefficients. Genetic correlations between adiposity traits were calculated using cross-trait LD score regressions [40] and GWAS summary statistics [34,35,36,37]. The LD score regressions were performed with pre-computed LD scores for each SNP using the 1000 Genomes European data (which are appropriate for use with European GWAS data [40]). We filtered our summary statistics to HapMap3 SNPs, because these are well-imputed in most studies.

Observational associations

Using linear regression, we examined cross-sectional associations of measured total and central adiposity with grip strength. Analyses were initially minimally adjusted for age (model 1); then additionally adjusted for the potential confounders listed above (model 2). To assess whether associations between adiposity and strength vary by age as has been proposed [41,42,43], we reran analyses stratified by age groups representing approximate fourths of the population (i.e. < 50 years, 50–59 years, 60–64 years, 65 years +), with tests of interaction between age group and each adiposity measure formally assessed.

Genetic associations

Briefly, the MR analysis (described below) requires information on associations between individual SNPs (i.e. our genetic instruments, denoted as G) and (i) our outcome, grip strength (denoted as GS) and (ii) our exposure (i.e. the adiposity trait of interest, denoted as X). We calculated individual SNPs genetic association with grip strength (represented by G-GS in Fig. 1) by running linear regressions (with adjustment for 10 genetic principal components); we used individual SNPs genetic association with each adiposity parameter, as reported in the original GWAS [34,35,36,37] (represented by G-X). We used a pseudo-two sample MR design, as we had some overlap between the discovery GWAS (for BMI and WHR) and our analytic sample (see the ‘Sensitivity analyses’ section).

MR analysis

We examined associations between adiposity and grip strength using four different MR approaches (three described here; one described in the ‘Sensitivity analyses’ section). Our main MR model, inverse-variance weighted MR (MR-IVW), estimates the effect of adiposity on grip strength by averaging the genetic instruments’ ratio of instrument–grip strength (G-GS) to instrument–adiposity (G-X) association estimates under a multiplicative random-effects meta-analysis, where the weight of each ratio was the inverse of the variance of the SNP–grip strength association [44, 45]. For the MR-IVW analysis, we report a measure of heterogeneity (I-squared statistic), as heterogeneity could indicate the presence of SNP outliers (which we investigated in the ‘Sensitivity analyses’ section). Our two additional MR analyses, MR-Egger [46] and weighted median MR (MR-WM) [47], allow for horizontal pleiotropy [48] (i.e. they allow for the effects of the genetic instruments on grip strength to not be exclusively via their effect on adiposity). MR-Egger produces an intercept term indicative of horizontal pleiotropy [46]; MR-WM gives valid estimates in the presence of horizontal pleiotropy, provided at least 50% of the information in the analysis comes from SNPs that have no pleiotropic effects [47]. When the MR-Egger intercept indicated pleiotropy (p < 0.05), we undertook two further analyses. First, funnel plots were examined to identify outlying SNPs, and second, we performed a leave-one-out MR-Egger analysis. We then reran our analyses removing any identified outliers.

The individual SNPs genetic association with each adiposity parameter (G-X) reported in the GWAS were scaled according to a standard deviation increment (SDX) of the adiposity trait in the discovery study. Hence, the MR analysis results in effects on grip strength of a one SD increase in the adiposity trait (according to the discovery sample). To ensure resulting coefficients are comparable, observational associations were scaled according to one SD of the adiposity measure of interest.

Sensitivity analyses

The GWAS from which we identified our BMI and WHR genetic instruments included UK Biobank participants: approximate sample overlap was 60% for BMI and 70% for WHR [36, 37]. We therefore needed to mitigate against over-estimating genetic effect sizes (i.e. winner’s curse bias [49]). We did this by calculating the expected bias and type 1 error rate, using a formula described elsewhere [49]. The expected bias is a linear function of the proportion of overlap between the samples and was calculated given the F parameter (the expected value of the F statistic), the observational estimate, the sample size and the sample overlap percentage (which we overestimated at 100% for both BMI and WHR). To assess the plausibility of assumptions that underlie our MR analysis, we examined associations between SNPs and potential confounders (Townsend score, smoking status, moderate and vigorous physical activity, and average alcohol intake) using linear/logistic regression as appropriate. Where associations were present, after adjusting for multiple testing using a Bonferroni correction (equating to p < 0.05), the MR analysis was re-run excluding potentially invalid SNPs. Finally, to evaluate the MR results by identifying and correcting for potential outliers (p < 0.05), we conducted a Mendelian Randomisation Pleiotropy RESidual Sum and Outlier analysis (by running the R function MR-PRESSO [50], with 50,000 bootstrap replications). This method evaluates genetic pleiotropy in the MR model, performs outlier removal, and performs MR again without the outliers to reduce bias in the MR estimates.

We used STATA 14, R, PLINK 2.0 and the command line tool ldsc [40] for data processing and statistical analyses. MR analyses were performed using the mrrobust package in STATA [45] and MR-PRESSO function in R [50].

Data availability

This work was conducted using the UK Biobank resource under application number 71702.


Mean maximum grip strength was higher in males (41.8 kg; SD = 8.9 kg) than females (25.1 kg; SD = 6.4 kg). Likewise, mean BMI, WC and WHR were higher in males than females, whereas females had higher mean BF% (Table 1).

Table 1 Characteristics (Mean(SD)/N(%)) of included UK Biobank study participants

Correlations between phenotypic and genetic adiposity measures and traits

Phenotypic and genetic correlations were broadly similar. For both phenotypic and genetic correlations and in both sexes, BMI and WC were highly correlated (phenotypic correlation coefficients = 0.88 for both sexes; genetic correlation coefficients = 0.94 (males)/0.90 (females), Additional File 1: Table S3). In females the BMI–WHR and BF%–WHR correlations were low (phenotypic correlation coefficients = 0.46 for both; genetic correlation coefficients = 0.46 and 0.36 respectively), while in males, these correlations were moderate (phenotypic correlation coefficients = 0.60 and 0.63 respectively; genetic correlation coefficients = 0.69 and 0.78 respectively).

Observational associations: measured adiposity and grip strength

In males, higher BMI and WC were associated with stronger grip, while higher BF% and WHR were associated with weaker grip (Fig. 2, Additional File 1: Table S4). For example, after adjustment for all covariates, a 1-SD higher BMI was associated with 0.49 kg (0.45 kg, 0.53 kg) stronger grip, while a 1-SD higher WHR was associated with 0.45 kg (0.41 kg, 0.48 kg) weaker grip. With the exception of WHR (pinteraction = 0.13), there was evidence that associations between adiposity and grip strength varied with age (pinteraction < 0.001). Relationships of BMI and WC with strength reduced with increasing age, while BF% associations strengthened with age (Fig. 3, Additional File 1: Table S5). For example, in males aged < 50 years, a 1-SD higher BMI was associated with 0.93 kg (0.84 kg, 1.01 kg) stronger grip, whereas among males aged 65 years + , the equivalent estimate was 0.13 kg (0.05 kg, 0.21 kg). Analogous estimates for a 1-SD higher BF% were 0.19 kg (0.10 kg, 0.28 kg) and 0.51 kg (0.43 kg, 0.59 kg) weaker grip for males aged < 50 years and 65 years + respectively.

Fig. 2
figure 2

Associations between one SD increases in measured and genetically predicted adiposity (BMI, BF%, WC and WHR) and grip strength in a males and b females. Numbers represent estimated mean difference in grip strength (kg) per 1 standard deviation higher (measured/genetically predicted) adiposity; p-pleiotropy: p-value for overall horizontal pleiotropic effect indicated by the intercept from MR-Egger regression; Obs: model 1 adjusted for age; Obs: model 2 additionally adjusts for Townsend deprivation, smoking, moderate and vigorous physical activity and alcohol intake; MR-IVW, Mendelian randomisation, inverse-variance-weighted; MR-WM, Mendelian randomisation, weighted median estimator; MR-Egger, Mendelian randomisation, Egger; SD, standard deviation; BMI, body mass index; BF%, body fat percentage; WC, waist circumference; WHR, waist hip ratio

Fig. 3
figure 3

Associations between one SD increases in measured adiposity (BMI, BF%, WC and WHR) and grip strength, stratified by age and sex. Associations adjusted for Townsend deprivation, smoking, moderate and vigorous physical activity and alcohol intake

In females, higher BMI and WC were associated with stronger grip strength, while higher BF% and WHR were associated with weaker grip (model 2; Fig. 2, Additional File 1: Table S4). For example, after adjustment for all covariates, a 1-SD higher WHR was associated with 0.20 kg (0.18 kg, 0.23 kg) weaker grip. There was evidence that all adiposity–grip strength associations varied with age (pinteraction < 0.01), although the magnitude of differences in associations by age were small (Fig. 3, Additional File 1: Table S5). For example, while there was no association between BMI and grip strength among females aged 50–59 years and 60–64 years, a 1-SD higher BMI was associated with 0.08 kg (0.03 kg, 0.13 kg) and 0.11 kg (0.05 kg, 0.18 kg) stronger grip among females aged < 50 years and 65 + years respectively.

MR associations between genetically predicted adiposity and grip strength

In males, with one exception (MR-Egger for BF%), all three sets of MR associations were directionally consistent with observed associations. For example, a 1-SD higher BMI was associated with 0.63 kg(0.34 kg, 0.91 kg) stronger grip (MR-IVW; Fig. 2, Additional File 1: Table S4). There was borderline evidence of horizontal pleiotropy for BF% (MR-Egger p-intercept = 0.05). Funnel plots and leave-one-out analyses identified three potentially pleiotropic SNPs (rs1558902, rs6738627 and rs9906944). When BF% analyses were re-run without these SNPs, all three sets of MR associations were directionally consistent with observed associations (Additional File 1: Table S6).

In females, directional consistency with observed associations were present for all three sets of MR associations for WC. In contrast to observed associations, all three sets of MR associations indicated that higher BMI was associated with weaker grip. For BF%, there was evidence of pleiotropy (MR-Egger p-intercept = 0.03), and when potentially pleiotropic SNPs were removed (rs1558902, rs6738627 and rs2943652), two MR associations (MR-IVW and MR-WM) were similar to observed associations, indicating higher BF% was associated with weaker grip (Additional File 1: Table S6). There was also evidence of horizontal pleiotropy for WHR (MR-Egger p-intercept = 0.001). However, both MR-WM and MR-Egger analyses demonstrated directionally consistent associations with grip strength. For example, a 1-SD higher WHR was associated with 0.27 kg (0.04 kg, 0.49 kg) stronger grip (MR-WM). When we excluded identified outlying SNPs (rs1406948, rs10132280, rs12774134), the MR-Egger intercept still indicated pleiotropy (p = 0.002); however, both the MR-Egger (slope) and MR-WM associations were similar to those reported in Fig. 2 (see Additional File 1: Table S4 and S6); removing one SNP at a time had little effect on the MR-Egger slope (range: 0.70–0.95) or constant (p ≤ 0.005 in all cases).

Any potential bias in our results due to sample overlap (i.e. because the GWAS from which we identified our BMI and WHR genetic instruments included UK Biobank participants) was small: over-estimating sample overlap at 100%, the absolute value of bias was less than 0.01 for both BMI and WHR, with type-1 error rate ≤ 0.06 (Additional File 1: Table S7). We found several associations between SNPs and potential confounders; however, when these SNPs were removed from analyses, results were similar to those presented in Fig. 2 (see Additional File 1: Table S4). There was evidence of heterogeneity for all associations (I2 = 29.8% to 75.6% (males); 66.0% to 78.7% (females); Additional File 1: Table S4) and MR-PRESSO provided evidence for outliers in all but one case (Additional File 1: Table S8). However, after outlier-correction, there was little change in the strength of evidence of associations.


We investigated evidence for links between different adiposity measures and grip strength in UK Biobank using several complementary approaches and found important sex-differences in associations. In males, our observational analyses indicated that higher BMI and WC were associated with stronger grip while higher BF% and WHR were associated with weaker grip. MR findings were generally directionally consistent with observational findings, providing evidence to suggest observed associations in males are causal. In females, our observational analyses indicated that higher BF% and WHR were associated with weaker grip, while higher BMI and WC were associated with stronger grip. In general, MR associations were only directionally consistent with observed associations for BF% and WC. Finally, our observational analyses suggest that adiposity–grip strength associations could vary by age, which may partly explain some observed inconsistencies.

Our study has several strengths. First, by using MR, we exploit the fact that adiposity alleles inherited by offspring from their parents are randomly distributed, ensuring our MR-associations are less subject to confounding and reverse causation [51]. Second, we adopted four different MR approaches which have distinct strengths and assumptions. The general concordance of results from these different MR approaches with each other and with our observational estimates (in males, and for BF% and WC in females) reinforces the conclusions drawn. Third, by utilising UK Biobank’s large sample size and including multiple genetic instruments, we increased the power of our MR analysis, mitigating against weak instrument bias [52, 53]. Fourth, pleiotropic effects were minimised through MR-Egger [46], MR-WM [47] and MR-PRESSO [50] analyses, and where required (i.e. in males for BF% and in females for BF% and WHR), we explored the effect of individual SNPs. Finally, we attempted to quantify the bias due to overlapping samples for our BMI and WHR analyses, by over-estimating sample overlap to 100%, and found the potential bias in our analyses to be small.

While MR has noteworthy advantages it depends on three main assumptions, the plausibility of which need to be assessed: (i) genetic instruments must associate with the different adiposity traits, (ii) genetic instruments must be independent of potential confounders of the adiposity–grip strength association and (iii) genetic instruments must affect grip strength only via their effect on adiposity (i.e. no horizontal pleiotropy). The first assumption is plausible because the SNPs used as instruments for our adiposity traits were identified from large GWAS [34,35,36,37]. While the second and third assumptions are harder to assess definitively, only a relatively small number of SNPs were associated with potential confounders and when we reran our MR analyses without these SNPs, results were similar. However, we acknowledge the possibility that there may be other unmeasured confounders, such as dietary patterns, which may explain the observed pleiotropic WHR associations in females. The assumption of no horizontal pleiotropy is particularly relevant for IVW-MR, because effect estimates can be biased in the presence of unbalanced (directional) horizontal pleiotropy [54]. Fortunately, pleiotropy was observed in only a few instances, and when analyses were rerun removing potentially pleiotropic SNPs, in all but one case (i.e. WHR associations in females), there was no more evidence of pleiotropy. Moreover, the other MR approaches we applied are robust to/correct for horizontal pleiotropy (i.e. MR-Egger [46], MR-WM [47] and MR-PRESSO [50]). Finally, all our MR analyses assume a linear dose–response relationship between adiposity traits and grip strength which may not provide an accurate picture of the shape of the relationship.

Other important methodological considerations include that our observational associations could be affected by measurement error. For example, BF% was estimated by bio-impedance, the accuracy of which depends on several factors [55]. Nonetheless, bio-impedance is a valid estimation technique for large epidemiological studies [56], such as UK Biobank. Rather than examining a single adiposity indicator (BMI) as in most previous work, we consider a range of measures including a measure of total adiposity that distinguishes fat from lean mass (BF%) and indicators of central adiposity (WC and WHR). Nevertheless, other novel adiposity measures such as visceral adipose tissue [57], ‘favourable’ and ‘unfavourable’ adiposity [58] were not considered and warrant investigation in future research. We were limited to using grip strength as our marker of muscle strength. Although grip strength is a convenient and commonly used proxy for overall body strength and the Jamar dynamometer used has good reliability and reproducibility [59], grip strength specifically measures upper limb strength. Evidence on whether grip strength is an adequate proxy for overall muscle strength is equivocal [60, 61] and relationships between adiposity and strength are likely to vary by location of strength measurement (e.g. loaded vs. unloaded muscle). In terms of generalizability of findings, our analysis was restricted to white European participants and thus we are unable to extrapolate to other ethnic groups. Additionally, patterns of selection into studies such as UK Biobank (i.e. “healthy volunteers” [62]) can induce collider bias. Even modest influences on selection could lead to biased estimates [63], and we acknowledge that such biases can affect both observational and instrumental variable analyses [64]. Therefore, future work is needed to assess whether our findings are replicated in other samples including those representing other ethnic groups.

Our findings for total and central adiposity in males broadly agree, in terms of direction of associations, with other studies [22]. Findings for females, both within our study and more generally, compared with the literature, are less consistent. For example, in observational analyses for females, we found higher BMI was associated with stronger grip, contrasting with a meta-analysis that found no association [22]. In observational analyses, for males, we found 0.12 kg stronger grip for a 1 kg/m2 higher BMI (i.e. mean difference in grip strength per BMI-SD (0.489)/BMI-SD (4.24)). This concurs with findings from a meta-analysis that in males (mean age ranging from 53 to 79 years), a 1 kg/m2 higher BMI was associated with 0.23 kg stronger grip [22]. Similar to us, the meta-analysis noted associations in males between BMI and grip were stronger at younger ages. While our MR analyses estimates the life-long effect of BMI on strength, it provides little information regarding the importance of BMI at specific life-stages. The importance of BMI at specific life-stages for strength is supported in the literature in terms of both empirical evidence and biological plausibility. For example, cross-sectional analyses of age-heterogeneous samples suggests that relationships between adiposity and muscle characteristics vary by age: muscle adapts beneficially to loading induced by adiposity at younger ages, but this benefit is not seen at older ages [41,42,43]. These age-related differences noted elsewhere [41,42,43] concur with our observations and need replication in cohorts of individuals with detailed repeat measures of both adiposity and strength over time. This is essential to understand how lifetime adiposity influences strength at specific life-stages and changes in strength over life. Underlying biological mechanisms explaining the changing relationship between adiposity and strength with age, including observations that with advancing age, chronic low-grade inflammation, insulin resistance and hormone dysregulation due to long-term exposure to obesity [65], could eventually override the beneficial anabolic stimulus to muscle provided by loading from adiposity in earlier adulthood. Future research should explore these underlying mechanisms with the adiposity measures examined here and other phenotypes such as ‘favourable’ and ‘unfavourable’ adiposity [58], which, although associated differentially with metabolic profiles, are similarly associated with inflammatory markers such as CRP [58].

Unlike BMI, BF% provides an indicator of total adiposity that distinguishes fat from lean mass, and reassuringly, higher BF% in both sexes was consistently associated with lower grip. This finding is important in highlighting the need to examine different dimensions of adiposity. Both BMI and BF% are markers of total adiposity and are correlated; however, the direction of association with strength varied for BMI and BF% in males. In females, the MR associations for BMI and BF% both indicated adverse associations with strength. These somewhat unexpected observations could be explained by BMI’s inability to differentiate between lean and fat mass and the observation that females tend to have proportionally more fat mass than males [66]. Therefore, at a population level, BMI in males might be more representative of lean mass and in females more representative of fat mass. In men, our finding that higher WC was related to stronger grip agrees with the meta-analysis [22]. WHR was only moderately correlated to BMI; hence, it is likely to be a more specific surrogate for central fat deposition (compared to WC). We found that in men, higher WHR was consistently associated with lower grip. For example (in observational analysis), for a man in UK Biobank with average hip circumference (104 cm), a 7 cm greater WC was associated with 0.45 kg weaker grip, and although the magnitude of association is small, it is relevant, because a 1 kg reduction in grip strength is associated with a 3% increase in mortality rates [8]. In females, while observational associations between BMI and WC concur, MR associations are in opposite directions, despite high levels of genetic correlation between the two traits. Moreover, our inability to explain pleiotropy in WHR associations for females is also concerning. Thus, our findings regarding associations between adiposity and grip strength in females warrant further investigation. Nonetheless, our findings for BF% in males and females and WHR in males add to the sparse literature to date and are noteworthy because both BF% and abdominal adiposity increase with age [19, 67].


The importance of maintaining muscle strength at older ages is increasingly being recognised [27]. Population ageing [6], coupled with current [17], and projected [18] obesity trends necessitate that we establish the influence of adiposity on muscle strength. Moreover, because ageing is associated with a progressive loss of subcutaneous fat and the accumulation of visceral and ectopic fat [68], it is important to elucidate how not only markers of total adiposity which distinguish between fat and muscle but also more specific adiposity markers influence strength. While acknowledging that relationships between adiposity and strength may vary with age and could be bi-directional [69], our consistent findings using different methodological approaches strengthens the evidence base for causal links between total adiposity and grip strength in males and females and between central adiposity and grip strength in males. We found that for both sexes, higher BF% and (in males only) WHR was associated with weaker grip strength. Pathways linking total and central adiposity to strength are likely to differ; for example, loci associated with BMI implicate pathways that act in the brain, whereas loci associated with fat distribution point to pathways involved in adipocyte biology and insulin resistance [70]. Further study is warranted to establish underlying mechanisms explaining our findings, before transitioning to clinical trials that can inform on the potential translation of these insights towards benefiting the general population.

Availability of data and materials

The data that support the findings of this study are available from UK Biobank project site, subject to successful registration and application process. Further details can be found at



Body Fat Percentage


Body Mass Index


Genome-Wide Association Studies


Mendelian Randomisation


Standard Deviation


Single Nucleotide Polymorphism


Waist Circumference




  1. Keevil VL, Romero-Ortuno R. Ageing well: a review of sarcopenia and frailty. Proc Nutr Soc. 2015;74(4):337–47.

    Article  PubMed  Google Scholar 

  2. Norman K, Otten L. Financial impact of sarcopenia or low muscle mass - a short review. Clin Nutr. 2019;38(4):1489–95.

    Article  PubMed  Google Scholar 

  3. Future of an Ageing Population. Government Office for Science. London: UK Foresight report; 2016.

  4. Hajek A, Bock JO, Saum KU, Matschinger H, Brenner H, Holleczek B, et al. Frailty and healthcare costs-longitudinal results of a prospective cohort study. Age Ageing. 2018;47(2):233–41.

    Article  PubMed  Google Scholar 

  5. Schaap LA, Koster A, Visser M. Adiposity, muscle mass, and muscle strength in relation to functional decline in older persons. Epidemiol Rev. 2013;35:51–65.

    Article  PubMed  Google Scholar 

  6. Kontis V, Bennett JE, Mathers CD, Li G, Foreman K, Ezzati M. Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble. Lancet. 2017;389(10076):1323–35.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A Jr, Orlandini A, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015;386(9990):266–73.

    Article  PubMed  Google Scholar 

  8. Cooper R, Kuh D, Hardy R, Mortality Review G, Falcon, Teams HAS. Objectively measured physical capability levels and mortality: systematic review and meta-analysis. BMJ. 2010;341:c4467.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Willems SM, Wright DJ, Day FR, Trajanoska K, Joshi PK, Morris JA, et al. Large-scale GWAS identifies multiple loci for hand grip strength providing biological insights into muscular fitness. Nat Commun. 2017;8:16015.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Celis-Morales CA, Welsh P, Lyall DM, Steell L, Petermann F, Anderson J, et al. Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants. BMJ. 2018;361:k1651.

    PubMed  PubMed Central  Google Scholar 

  11. Dodds RM, Syddall HE, Cooper R, Benzeval M, Deary IJ, Dennison EM, et al. Grip strength across the life course: normative data from twelve British studies. PLoS ONE. 2014;9(12):e113637.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Cruz-Jentoft AJ, Sayer AA. Sarcopenia Lancet. 2019;393(10191):2636–46.

    Article  PubMed  Google Scholar 

  13. Shaw SC, Dennison EM, Cooper C. Epidemiology of sarcopenia: determinants throughout the lifecourse. Calcif Tissue Int. 2017;101(3):229–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kim Y, Wijndaele K, Lee DC, Sharp SJ, Wareham N, Brage S. Independent and joint associations of grip strength and adiposity with all-cause and cardiovascular disease mortality in 403,199 adults: the UK Biobank study. Am J Clin Nutr. 2017;106(3):773–82.

    CAS  PubMed  Google Scholar 

  15. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004;79(3):379–84.

    Article  CAS  PubMed  Google Scholar 

  16. Schneider HJ, Friedrich N, Klotsche J, Pieper L, Nauck M, John U, et al. The predictive value of different measures of obesity for incident cardiovascular events and mortality. J Clin Endocrinol Metab. 2010;95(4):1777–85.

    Article  CAS  PubMed  Google Scholar 

  17. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–81.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Johnson W, Li L, Kuh D, Hardy R. How has the age-related process of overweight or obesity development changed over time? Co-ordinated analyses of individual participant data from five United Kingdom birth cohorts. PLoS Med. 2015;12(5):e1001828 (discussion e).

    Article  PubMed  PubMed Central  Google Scholar 

  19. Meeuwsen S, Horgan GW, Elia M. The relationship between BMI and percent body fat, measured by bioelectrical impedance, in a large adult sample is curvilinear and influenced by age and sex. Clin Nutr. 2010;29(5):560–6.

    Article  CAS  PubMed  Google Scholar 

  20. Stenholm S, Sallinen J, Koster A, Rantanen T, Sainio P, Heliovaara M, et al. Association between obesity history and hand grip strength in older adults–exploring the roles of inflammation and insulin resistance as mediating factors. J Gerontol A Biol Sci Med Sci. 2011;66(3):341–8.

    Article  PubMed  Google Scholar 

  21. Keevil VL, Luben R, Dalzell N, Hayat S, Sayer AA, Wareham NJ, et al. Cross-sectional associations between different measures of obesity and muscle strength in men and women in a British cohort study. J Nutr Health Aging. 2015;19(1):3–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Hardy R, Cooper R, Aihie Sayer A, Ben-Shlomo Y, Cooper C, Deary IJ, et al. Body mass index, muscle strength and physical performance in older adults from eight cohort studies: the HALCyon programme. PLoS ONE. 2013;8(2):e56483.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Cooper R, Hardy R, Bann D, Aihie Sayer A, Ward KA, Adams JE, et al. Body mass index from age 15 years onwards and muscle mass, strength, and quality in early old age: findings from the MRC National Survey of Health and Development. J Gerontol A Biol Sci Med Sci. 2014;69(10):1253–9.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Cooper R, Tomlinson DJ, Hamer M, Pinto Pereira SM. Lifetime body mass index and grip strength at age 46y: the 1970 British Cohort Study. J Cachexia Sarcopenia Muscle. 2022;(in press).

  25. Schrager MA, Metter EJ, Simonsick E, Ble A, Bandinelli S, Lauretani F, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol (1985). 2007;102(3):919–25.

    Article  Google Scholar 

  26. Tuttle CSL, Thang LAN, Maier AB. Markers of inflammation and their association with muscle strength and mass: a systematic review and meta-analysis. Ageing Res Rev. 2020;64: 101185.

    Article  CAS  PubMed  Google Scholar 

  27. Muscle and bone strengthening and balance activities for general health benefits in adults and older adults: Summary of a rapid evidence review for the UK Chief Medical Officers’ update of the physical activity guidelines. London: Public Health England; 2018.

  28. Schmitz KH, Hannan PJ, Stovitz SD, Bryan CJ, Warren M, Jensen MD. Strength training and adiposity in premenopausal women: strong, healthy, and empowered study. Am J Clin Nutr. 2007;86(3):566–72.

    Article  CAS  PubMed  Google Scholar 

  29. UK Biobank. Protocol for a large-scale prospective epidemiological resource Centre UBC. 2007.

    Google Scholar 

  30. Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.

    Article  PubMed  PubMed Central  Google Scholar 

  31. UK Biobank. UKB : Resource 100232: Grip-strength measurement using ACE. 2011.

    Google Scholar 

  32. Farmer RE, Mathur R, Schmidt AF, Bhaskaran K, Fatemifar G, Eastwood SV, et al. Associations between measures of sarcopenic obesity and risk of cardiovascular disease and mortality: a cohort study and mendelian randomization analysis using the UK Biobank. J Am Heart Assoc. 2019;8(13): e011638.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Townsend P. Deprivation. J. Soc Policy. 1987;16:125–46.

    Article  Google Scholar 

  34. Lu Y, Day FR, Gustafsson S, Buchkovich ML, Na J, Bataille V, et al. New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk. Nat Commun. 2016;7:10495.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Shungin D, Winkler TW, Croteau-Chonka DC, Ferreira T, Locke AE, Magi R, et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature. 2015;518(7538):187–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Pulit SL, Stoneman C, Morris AP, Wood AR, Glastonbury CA, Tyrrell J, et al. Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry. Hum Mol Genet. 2019;28(1):166–74.

    Article  CAS  PubMed  Google Scholar 

  37. Yengo L, Sidorenko J, Kemper KE, Zheng Z, Wood AR, Weedon MN, et al. Meta-analysis of genome-wide association studies for height and body mass index in approximately 700000 individuals of European ancestry. Hum Mol Genet. 2018;27(20):3641–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Henry A, Katsoulis M, Masi S, Fatemifar G, Denaxas S, Acosta D, et al. The relationship between sleep duration, cognition and dementia: a Mendelian randomization study. Int J Epidemiol. 2019;48(3):849–60.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562(7726):203–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Bulik-Sullivan B, Finucane HK, Anttila V, Gusev A, Day FR, Loh PR, et al. An atlas of genetic correlations across human diseases and traits. Nat Genet. 2015;47(11):1236–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Tomlinson DJ, Erskine RM, Morse CI, Pappachan JM, Sanderson-Gillard E, Onambele-Pearson GL. The combined effects of obesity and ageing on skeletal muscle function and tendon properties in vivo in men. Endocrine. 2021;72(2):411–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Tomlinson DJ, Erskine RM, Winwood K, Morse CI, Onambele GL. The impact of obesity on skeletal muscle architecture in untrained young vs. old women. J Anat. 2014;225(6):675–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Tomlinson DJ, Erskine RM, Morse CI, Winwood K, Onambele-Pearson G. The impact of obesity on skeletal muscle strength and structure through adolescence to old age. Biogerontol. 2016;17(3):467–83.

    Article  CAS  Google Scholar 

  44. Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med. 1999;18(20):2693–708.

    Article  CAS  PubMed  Google Scholar 

  45. Spiller W, Davies NM, Palmer TM. Software application profile: mrrobust-a tool for performing two-sample summary Mendelian randomization analyses. Int J Epidemiol. 2019;48(3):684–90.

    Article  Google Scholar 

  46. Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–25.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304–14.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23(R1):R89-98.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Burgess S, Davies NM, Thompson SG. Bias due to participant overlap in two-sample Mendelian randomization. Genet Epidemiol. 2016;40(7):597–608.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133–63.

    Article  PubMed  Google Scholar 

  52. Burgess S, Thompson SG. Bias in causal estimates from Mendelian randomization studies with weak instruments. Stat Med. 2011;30(11):1312–23.

    Article  PubMed  Google Scholar 

  53. Burgess S, Thompson SG, Collaboration CCG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40(3):755–64.

    Article  PubMed  Google Scholar 

  54. Hemani G, Bowden J, Davey SG. Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum Mol Genet. 2018;27(R2):R195–208.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Dehghan M, Merchant AT. Is bioelectrical impedance accurate for use in large epidemiological studies? Nutr J. 2008;7:26.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Bohm A, Heitmann BL. The use of bioelectrical impedance analysis for body composition in epidemiological studies. Eur J Clin Nutr. 2013;67:S79–85.

    Article  PubMed  Google Scholar 

  57. Karlsson T, Rask-Andersen M, Pan G, Hoglund J, Wadelius C, Ek WE, et al. Contribution of genetics to visceral adiposity and its relation to cardiovascular and metabolic disease. Nat Med. 2019;25(9):1390–5.

    Article  CAS  PubMed  Google Scholar 

  58. Martin S, Cule M, Basty N, Tyrrell J, Beaumont RN, Wood AR, et al. Genetic evidence for different adiposity phenotypes and their opposing influences on ectopic fat and risk of cardiometabolic disease. Diabetes. 2021;70(8):1843–56.

    Article  CAS  PubMed  Google Scholar 

  59. Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall H, Cooper C, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011;40(4):423–9.

    Article  PubMed  Google Scholar 

  60. Bohannon RW, Magasi SR, Bubela DJ, Wang YC, Gershon RC. Grip and knee extension muscle strength reflect a common construct among adults. Muscle Nerve. 2012;46(4):555–8.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Yeung SSY, Reijnierse EM, Trappenburg MC, Hogrel JY, McPhee JS, Piasecki M, et al. Handgrip strength cannot be assumed a proxy for overall muscle strength. J Am Med Dir Assoc. 2018;19(8):703–9.

    Article  PubMed  Google Scholar 

  62. Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, et al. Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am J Epidemiol. 2017;186(9):1026–34.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Munafo MR, Tilling K, Taylor AE, Evans DM, Smith GD. Collider scope: when selection bias can substantially influence observed associations. Int J Epidemiol. 2018;47(1):226–35.

    Article  PubMed  Google Scholar 

  64. Hughes RA, Davies NM, Davey Smith G, Tilling K. Selection bias when estimating average treatment effects using one-sample instrumental variable analysis. Epidemiol. 2019;30(3):350–7.

    Article  Google Scholar 

  65. Timpson NJ, Nordestgaard BG, Harbord RM, Zacho J, Frayling TM, Tybjaerg-Hansen A, et al. C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization. Int J Obes (Lond). 2011;35(2):300–8.

    Article  CAS  Google Scholar 

  66. Power ML, Schulkin J. Sex differences in fat storage, fat metabolism, and the health risks from obesity: possible evolutionary origins. Br J Nutr. 2008;99(5):931–40.

    Article  CAS  PubMed  Google Scholar 

  67. Jacobsen BK, Aars NA. Changes in waist circumference and the prevalence of abdominal obesity during 1994–2008 - cross-sectional and longitudinal results from two surveys: the Tromso Study. BMC Obes. 2016;3:41.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Buch A, Carmeli E, Boker LK, Marcus Y, Shefer G, Kis O, et al. Muscle function and fat content in relation to sarcopenia, obesity and frailty of old age–an overview. Exp Gerontol. 2016;76:25–32.

    Article  PubMed  Google Scholar 

  69. Jones G, Trajanoska K, Santanasto AJ, Stringa N, Kuo CL, Atkins JL, et al. Genome-wide meta-analysis of muscle weakness identifies 15 susceptibility loci in older men and women. Nat Commun. 2021;12(1):654.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Loos RJ. The genetics of adiposity. Curr Opin Genet Dev. 2018;50:86–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references


This work was conducted using the UK Biobank resource under application number 71702.


This work was conducted under the approved UK Biobank project number 71702. We thank the volunteer participants of the UK Biobank and the UK Biobank researchers. The work was supported by a UK Medical Research Council Career Development Award (ref: MR/P020372/1) to SMPP. VG and AF were supported by a joint Diabetes UK and British Heart Foundation grant (ref: 15/0005250). CF received additional support from the National Institute for Health Research University College London Hospitals Biomedical Research Centre. The views expressed in the publication are those of the authors and not necessarily those of the funders. The funders had no input into study design; data collection, analysis, and interpretation; in the writing of the report; and in the decision to submit the article for publication. Researchers were independent of influence from study funders.

Author information

Authors and Affiliations



SMPP wrote the first draft with input from RC and VG. SMPP, VG, AF, GF, TN, SD and CF prepared the data for analysis. SMPP and TN analysed the data with input from VG, AF and RC. SMPP and RC developed the study objectives. SMPP, DT and RC interpreted the key findings. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Snehal M. Pinto Pereira.

Ethics declarations

Ethics approval and consent to participate

All participants gave informed consent for data provision. UK Biobank has full ethical approval from the NHS National Research Ethics Service (16/NW/0274).

Consent for publication

The authors confirm that this manuscript does not contain any personal data or images from any individual participants.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Tables S1-S8. Table S1.

R-squared and F-statistic of adiposity genetic instruments. Table S2. Summary statistics describing SNP associations with (i) adiposity exposures (BMI, BF%, WC and WHR) and (ii) grip strength. Table S3. Correlation coefficients between adiposity measures for males and females: (a) phenotypic correlations, (b) genetic correlations. Table S4. Mean difference (95% CI) in grip strength (kg) by markers of total and central adiposity. Table S5. Mean difference (95% CI) in grip strength (kg) by markers of total and central adiposity, stratified by age. Table S6. Mean difference (95% CI) in grip strength (kg) by markers of total and central adiposity: exploring pleiotropy. Table S7. Estimation of bias due to sample overlap. Table S8. MR PRESSO Outlier correction.

Additional file 2: Figure S1.

Genetic instrument selection process.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Pinto Pereira, S.M., Garfield, V., Farmaki, AE. et al. Adiposity and grip strength: a Mendelian randomisation study in UK Biobank. BMC Med 20, 201 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: